SG Americas Securities
CGON icon

SG Americas Securities’s CG Oncology CGON Stock Holding History

SG Americas Securities’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.6M Buy
867,465
+842,833
+3,422% +$55.1M 0.03% 310
2026
Q1 		$1.67M Buy
24,632
+3,683
+18% +$209K ﹤0.01% 1482
2025
Q4 		$870K Buy
20,949
+10,077
+93% +$417K ﹤0.01% 2126
2025
Q3 		$438K Buy
10,872
+1,601
+17% +$46.5K ﹤0.01% 2209
2025
Q2 		$241K Buy
9,271
+3,792
+69% +$91.4K ﹤0.01% 2148
2025
Q1 		$134K Buy
+5,479
New +$154K ﹤0.01% 2836
2024
Q4 		– Sell
-17,595
Closed -$664K – 3194
2024
Q3 		$664K Buy
+17,595
New +$617K ﹤0.01% 1439

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities's CGON Position: Q2 2026 in Review

SG Americas Securities increased its CG Oncology (CGON) stake by 3,422% in Q2 2026, buying an estimated $55.1M and bringing the position to 867,465 shares worth $61.6M. The position accounts for 0.03% of the portfolio, ranked #310.

SG Americas Securities first reported a position in CGON in Q3 2024 and has held it in 7 quarters since. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • SG Americas Securities held 867,465 shares of CG Oncology worth $61.6M as of Q2 2026.
  • SG Americas Securities bought 842,833 CG Oncology shares in Q2 2026, an estimated $55.1M.
  • CG Oncology made up 0.03% of SG Americas Securities's portfolio in Q2 2026, its #310 holding.
  • SG Americas Securities first reported a position in CG Oncology in Q3 2024 and has held it in 7 quarters since.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.